FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors - eviltoast
The FDA approved Ogsiveo tablets for adult patients with progressing desmoid tumors who require systemic treatment.

Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas.